Emre Deniz

405 total citations
9 papers, 279 citations indexed

About

Emre Deniz is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Emre Deniz has authored 9 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Emre Deniz's work include RNA Research and Splicing (3 papers), RNA modifications and cancer (2 papers) and T-cell and B-cell Immunology (2 papers). Emre Deniz is often cited by papers focused on RNA Research and Splicing (3 papers), RNA modifications and cancer (2 papers) and T-cell and B-cell Immunology (2 papers). Emre Deniz collaborates with scholars based in Türkiye, United States and Austria. Emre Deniz's co-authors include Batu Erman, Belkıs Atasever Arslan, Tülin Erşahin, Rengül Çetin-Atalay, Wilfried Ellmeier, Shinya Sakaguchi, Selim Çetiner, Hazal Gür, Hilary R. Keller and Jung‐Hyun Park and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Emre Deniz

9 papers receiving 276 citations

Peers

Emre Deniz

MB

CR

IMMUN

ONCOL

GENET

Maria C. Passarelli United States

Indrabahadur Singh Germany

Hengji Zhan China

Huaibing Luo China

Anneleen Decock Belgium

Shuheng Wu China

Ying Kong China

Wenhao Li China

Marie K. Kirby United States

Maria C. Passarelli United States

Emre Deniz

304 ×1.6

MB

99 ×0.6

CR

20 ×0.5

IMMUN

22 ×0.9

ONCOL

11 ×0.6

GENET

Citations per year, relative to Emre Deniz Emre Deniz (= 1×) peers Maria C. Passarelli

Countries citing papers authored by Emre Deniz

Since Specialization

Citations

This map shows the geographic impact of Emre Deniz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Deniz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Deniz more than expected).

Fields of papers citing papers by Emre Deniz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Deniz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Deniz. The network helps show where Emre Deniz may publish in the future.

Co-authorship network of co-authors of Emre Deniz

This figure shows the co-authorship network connecting the top 25 collaborators of Emre Deniz. A scholar is included among the top collaborators of Emre Deniz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre Deniz. Emre Deniz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Deniz, Emre, et al.. (2024). Anticancer Drugs of Lysine Specific Histone Demethylase-1 (LSD1) Display Variable Inhibition on Nucleosome Substrates. Biochemistry. 63(11). 1369–1375. 4 indexed citations

2.

Song, Young, Purushottam B. Tiwari, Hsien-Chao Chou, et al.. (2023). Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity. Cancer Research Communications. 3(10). 2030–2043. 3 indexed citations

3.

Balaraman, Kaluvu, et al.. (2023). Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability. European Journal of Medicinal Chemistry. 251. 115244–115244. 3 indexed citations

4.

Deniz, Emre, et al.. (2022). Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth. PLoS ONE. 17(6). e0268391–e0268391. 10 indexed citations

5.

Deniz, Emre & Batu Erman. (2016). Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Functional & Integrative Genomics. 17(2-3). 135–143. 180 indexed citations

6.

Arslan, Belkıs Atasever, et al.. (2015). Screening of new antileukemic agents from essential oils of algae extracts and computational modeling of their interactions with intracellular signaling nodes. European Journal of Pharmaceutical Sciences. 83. 120–131. 24 indexed citations

7.

Deniz, Emre, Tülin Erşahin, Rengül Çetin-Atalay, et al.. (2015). PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function. Molecular and Cellular Biology. 35(10). 1741–1753. 28 indexed citations

8.

Belkaya, Serkan, et al.. (2012). Cd81 Interacts with the T Cell Receptor to Suppress Signaling. PLoS ONE. 7(11). e50396–e50396. 10 indexed citations

9.

Ligons, Davinna L., Ceren Tuncer Şakar, Sema Kurtuluş, et al.. (2012). CD8 Lineage-specific Regulation of Interleukin-7 Receptor Expression by the Transcriptional Repressor Gfi1. Journal of Biological Chemistry. 287(41). 34386–34399. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact